BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 18687556)

  • 21. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
    Marty FM; Cosimi LA; Baden LR
    N Engl J Med; 2004 Feb; 350(9):950-2. PubMed ID: 14985500
    [No Abstract]   [Full Text] [Related]  

  • 22. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
    Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel cause of invasive pulmonary infection in an immunocompetent patient: Aspergillus candidus.
    Ribeiro SC; Santana AN; Arriagada GH; Martins JE; Takagaki TY
    J Infect; 2005 Nov; 51(4):e195-7. PubMed ID: 16291268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated invasive aspergillosis in an apparently immunocompetent host.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
    Hashemi SB; Shishegar M; Nikeghbalian S; Salahi H; Bahador A; Kazemi K; Dehghani M; Kakaei F; Gholami S; Janghorban P; Malek-Hosseini SA
    Transplant Proc; 2009 Sep; 41(7):2933-5. PubMed ID: 19765479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspergillus "fungus ball" of the bladder after hematopoietic transplantation in a pediatric patient: successful treatment with intravesical voriconazole and surgery.
    González-Vicent M; Lassaletta A; López-Pino MA; Romero-Tejada JC; de la Fuente-Trabado M; Díaz MA
    Pediatr Transplant; 2008 Mar; 12(2):242-5. PubMed ID: 18266800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aspergillus galactomannan detection in allogenic hematopoietic cell transplantation].
    Rovira Tarrats M; Puig de la Bellacasa J
    Rev Iberoam Micol; 2003 Sep; 20(3):111-5. PubMed ID: 15456367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Ito JI; Chandrasekar PH; Hooshmand-Rad R
    Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
    Stanzani M; Vianelli N; Bandini G; Paolini S; Arpinati M; Bonifazi F; Giannini B; Agostinelli C; Baccarani M; Ricci P
    J Infect; 2006 Dec; 53(6):e243-6. PubMed ID: 16584783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination antifungal therapy in hematopoietic stem cell transplantation patients].
    Jacoby E; Keller N; Barkai G
    Harefuah; 2012 Aug; 151(8):455-7, 499, 498. PubMed ID: 23350288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
    Manavathu EK; Cutright JL; Chandrasekar PH
    Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
    Gutierrez F; Masia M; Ramos JM; Elia M; Rodriguez-Tudela JL; Cuenca-Estrella M
    Clin Infect Dis; 2005 Jun; 40(11):1706-7. PubMed ID: 15889381
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
    van 't Hek LG; Verweij PE; Weemaes CM; van Dalen R; Yntema JB; Meis JF
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1694-6. PubMed ID: 9603157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect.
    Soubani AO; Qureshi MA
    Haematologia (Budap); 2002; 32(4):427-37. PubMed ID: 12803117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous aspergillosis in a lung transplant recipient.
    Ramos A; Ussetti P; Laporta R; Lázaro MT; Sánchez-Romero I
    Transpl Infect Dis; 2009 Oct; 11(5):471-3. PubMed ID: 19622116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation.
    Mousset S; Bug G; Heinz WJ; Tintelnot K; Rickerts V
    Transpl Infect Dis; 2010 Jun; 12(3):261-4. PubMed ID: 19954497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive subglottal aspergillosis in a patient with severe aplastic anemia: a case report.
    Nagasawa M; Itoh S; Tomizawa D; Kajiwara M; Sugimoto T; Kumagai J
    J Infect; 2002 Apr; 44(3):198-201. PubMed ID: 12099752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
    Imhof A; Balajee SA; Fredricks DN; Englund JA; Marr KA
    Clin Infect Dis; 2004 Sep; 39(5):743-6. PubMed ID: 15356792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal myocardial aspergillosis in an immunosuppressed child.
    Ozsahin H; Wacker P; Brundler MA; Starobinski M; Helg C; Pastore Y; Miralbell R; Hanquinet S; Gervaix A; Chapuis B; Humbert J
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):456-9. PubMed ID: 11878582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.